FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093031070> ?p ?o ?g. }

• W3093031070 endingPage "515" @default.
• W3093031070 startingPage "507" @default.
• W3093031070 abstract "Abstract Purpose To update and expand on data related to treatment, resource utilization, and costs by cancer stage in Canadian patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast cancer (BC). Methods We analyzed data for adult women diagnosed with invasive HR+/HER2− BC between 2012 and 2016 utilizing the publicly funded health care system in Ontario. Baseline characteristics, treatment received, and health care use were descriptively compared by cancer stage (I–III vs. IV). Resource use was multiplied by unit costs for publicly funded health care services to calculate costs. Results Our study included 21,360 patients with stage I–III plus 813 with stage IV HR+/HER2− BC. Surgery was performed on 20,510 patients with stage I–III disease (96.0%), with the majority having a lumpectomy, and radiation was received by 15,934 (74.6%). Few ( n = 1601, 7.8%) received neoadjuvant and most ( n = 15,655, 76.3%) received adjuvant systemic treatment. Seven hundred and fifty eight patients with metastatic disease (93.2%) received systemic therapy; 542 (66.7%) received endocrine therapy. Annual per patient health care costs were three times higher in the stage IV vs. stage I–III cohort with inpatient hospital services representing nearly 40% of total costs. Conclusion The costs associated with metastatic HR+/HER2− BC reflect a significant disease burden. Low endocrine treatment rates captured by the publicly funded system suggest guideline non-adherence or that a fair portion of Ontarian patients may be incurring out-of-pocket drug costs." @default.
• W3093031070 created "2020-10-22" @default.
• W3093031070 creator A5014417033 @default.
• W3093031070 creator A5022801937 @default.
• W3093031070 creator A5038862491 @default.
• W3093031070 creator A5049035942 @default.
• W3093031070 creator A5057024351 @default.
• W3093031070 creator A5022231179 @default.
• W3093031070 date "2020-10-16" @default.
• W3093031070 modified "2023-09-29" @default.
• W3093031070 title "A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer" @default.
• W3093031070 cites W1518987711 @default.
• W3093031070 cites W1607215679 @default.
• W3093031070 cites W1961026612 @default.
• W3093031070 cites W1974685860 @default.
• W3093031070 cites W2000445173 @default.
• W3093031070 cites W2009258470 @default.
• W3093031070 cites W2023920949 @default.
• W3093031070 cites W2042056111 @default.
• W3093031070 cites W2063624148 @default.
• W3093031070 cites W2103157783 @default.
• W3093031070 cites W2106286200 @default.
• W3093031070 cites W2116144791 @default.
• W3093031070 cites W2122344453 @default.
• W3093031070 cites W2127209321 @default.
• W3093031070 cites W2128883808 @default.
• W3093031070 cites W2130900820 @default.
• W3093031070 cites W2131199058 @default.
• W3093031070 cites W2154877455 @default.
• W3093031070 cites W2160786885 @default.
• W3093031070 cites W2161426850 @default.
• W3093031070 cites W2397748587 @default.
• W3093031070 cites W2404884142 @default.
• W3093031070 cites W2460946808 @default.
• W3093031070 cites W2463707783 @default.
• W3093031070 cites W2584887085 @default.
• W3093031070 cites W2598732486 @default.
• W3093031070 cites W2615369972 @default.
• W3093031070 cites W2769781213 @default.
• W3093031070 cites W2771675563 @default.
• W3093031070 cites W2795120383 @default.
• W3093031070 cites W2796824128 @default.
• W3093031070 cites W2801758612 @default.
• W3093031070 cites W2805669343 @default.
• W3093031070 cites W282724840 @default.
• W3093031070 cites W2884327845 @default.
• W3093031070 cites W2904991649 @default.
• W3093031070 cites W2912993657 @default.
• W3093031070 cites W2943072932 @default.
• W3093031070 cites W2947052057 @default.
• W3093031070 cites W2952164772 @default.
• W3093031070 cites W3010681060 @default.
• W3093031070 cites W3029560485 @default.
• W3093031070 cites W3033718997 @default.
• W3093031070 cites W3081090980 @default.
• W3093031070 cites W4285675841 @default.
• W3093031070 cites W4376849581 @default.
• W3093031070 doi "https://doi.org/10.1007/s10549-020-05960-4" @default.
• W3093031070 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7867554" @default.
• W3093031070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33064230" @default.
• W3093031070 hasPublicationYear "2020" @default.
• W3093031070 type Work @default.
• W3093031070 sameAs 3093031070 @default.
• W3093031070 citedByCount "5" @default.
• W3093031070 countsByYear W30930310702022 @default.
• W3093031070 countsByYear W30930310702023 @default.
• W3093031070 crossrefType "journal-article" @default.
• W3093031070 hasAuthorship W3093031070A5014417033 @default.
• W3093031070 hasAuthorship W3093031070A5022231179 @default.
• W3093031070 hasAuthorship W3093031070A5022801937 @default.
• W3093031070 hasAuthorship W3093031070A5038862491 @default.
• W3093031070 hasAuthorship W3093031070A5049035942 @default.
• W3093031070 hasAuthorship W3093031070A5057024351 @default.
• W3093031070 hasBestOaLocation W30930310701 @default.
• W3093031070 hasConcept C121608353 @default.
• W3093031070 hasConcept C126322002 @default.
• W3093031070 hasConcept C143998085 @default.
• W3093031070 hasConcept C146357865 @default.
• W3093031070 hasConcept C151730666 @default.
• W3093031070 hasConcept C160735492 @default.
• W3093031070 hasConcept C162324750 @default.
• W3093031070 hasConcept C2776135927 @default.
• W3093031070 hasConcept C2777757722 @default.
• W3093031070 hasConcept C2778527826 @default.
• W3093031070 hasConcept C2779572924 @default.
• W3093031070 hasConcept C2908647359 @default.
• W3093031070 hasConcept C29456083 @default.
• W3093031070 hasConcept C50522688 @default.
• W3093031070 hasConcept C512399662 @default.
• W3093031070 hasConcept C530470458 @default.
• W3093031070 hasConcept C71924100 @default.
• W3093031070 hasConcept C72563966 @default.
• W3093031070 hasConcept C86803240 @default.
• W3093031070 hasConcept C99454951 @default.
• W3093031070 hasConceptScore W3093031070C121608353 @default.
• W3093031070 hasConceptScore W3093031070C126322002 @default.
• W3093031070 hasConceptScore W3093031070C143998085 @default.
• W3093031070 hasConceptScore W3093031070C146357865 @default.

• next